Henry Schein, Inc. (NASDAQ:HSIC) Given Average Rating of “Hold” by Brokerages

Henry Schein, Inc. (NASDAQ:HSIC) has earned a consensus recommendation of “Hold” from the eleven ratings firms that are presently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell rating, five have assigned a hold rating and five have given a buy rating to the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $81.73.

HSIC has been the subject of a number of research analyst reports. JPMorgan Chase & Co. upped their price target on Henry Schein from $82.00 to $88.00 and gave the company an “overweight” rating in a report on Wednesday, March 6th. Jefferies Financial Group increased their target price on shares of Henry Schein from $74.00 to $81.00 and gave the company a “hold” rating in a research report on Wednesday, March 6th. Piper Sandler reissued an “overweight” rating and issued a $86.00 price target on shares of Henry Schein in a research report on Friday, June 21st. UBS Group dropped their price objective on Henry Schein from $82.00 to $80.00 and set a “neutral” rating on the stock in a report on Wednesday, May 8th. Finally, Barrington Research lifted their target price on Henry Schein from $90.00 to $92.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 8th.

Henry Schein Trading Up 1.6 %

Shares of NASDAQ:HSIC opened at $65.11 on Tuesday. The company has a market cap of $8.34 billion, a PE ratio of 22.00, a P/E/G ratio of 1.58 and a beta of 0.87. The company’s 50 day moving average is $69.77 and its two-hundred day moving average is $72.81. Henry Schein has a 52 week low of $60.01 and a 52 week high of $82.63. The company has a current ratio of 1.75, a quick ratio of 1.02 and a debt-to-equity ratio of 0.47.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, May 7th. The company reported $1.10 earnings per share for the quarter, beating analysts’ consensus estimates of $1.01 by $0.09. The company had revenue of $3.17 billion for the quarter, compared to analysts’ expectations of $3.21 billion. Henry Schein had a return on equity of 13.51% and a net margin of 3.12%. Henry Schein’s quarterly revenue was up 3.7% on a year-over-year basis. During the same period last year, the firm earned $1.21 earnings per share. Equities analysts predict that Henry Schein will post 5.16 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of HSIC. McGlone Suttner Wealth Management Inc. purchased a new position in Henry Schein in the 4th quarter valued at $39,000. Neo Ivy Capital Management purchased a new stake in shares of Henry Schein in the third quarter valued at about $46,000. Mather Group LLC. acquired a new position in shares of Henry Schein during the first quarter worth about $97,000. Palisade Asset Management LLC acquired a new position in shares of Henry Schein during the first quarter worth about $113,000. Finally, Benjamin F. Edwards & Company Inc. raised its holdings in Henry Schein by 37.8% during the fourth quarter. Benjamin F. Edwards & Company Inc. now owns 1,516 shares of the company’s stock worth $114,000 after purchasing an additional 416 shares in the last quarter. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.